Mark Plautz

449 total citations
7 papers, 195 citations indexed

About

Mark Plautz is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Hematology. According to data from OpenAlex, Mark Plautz has authored 7 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 2 papers in Hematology. Recurrent topics in Mark Plautz's work include Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Respiratory Support and Mechanisms (2 papers) and Asthma and respiratory diseases (2 papers). Mark Plautz is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Respiratory Support and Mechanisms (2 papers) and Asthma and respiratory diseases (2 papers). Mark Plautz collaborates with scholars based in United States, Germany and Egypt. Mark Plautz's co-authors include Lewis Wesselius, Amy O’Brien-Ladner, Michael B. Liewen, Steven Kesten, D. E. Niewoehner, Craig A. Piquette, Michael P. Habib, Carlos A. Camargo, Charles E. McCulloch and Oommen John and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Journal of Food Protection.

In The Last Decade

Mark Plautz

7 papers receiving 185 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Plautz United States	5	97	47	40	27	23	7	195
Somayeh Jahani‐Sherafat Iran	8	16 0.2×	107 2.3×	19 0.5×	34 1.3×	10 0.4×	29	246
Maryam Dadashi Iran	5	123 1.3×	175 3.7×	13 0.3×	31 1.1×	3 0.1×	10	343
Mario Díaz Argentina	9	27 0.3×	29 0.6×	23 0.6×	13 0.5×	9 0.4×	13	202
Padmanaban Venkatesan India	7	22 0.2×	72 1.5×	45 1.1×	64 2.4×	4 0.2×	17	314
Yoshitaro Heshiki Germany	5	26 0.3×	229 4.9×	59 1.5×	23 0.9×	12 0.5×	6	322
A. A. Martin Australia	9	39 0.4×	69 1.5×	71 1.8×	14 0.5×	5 0.2×	14	385
Andrew Chou United States	9	18 0.2×	160 3.4×	27 0.7×	51 1.9×	3 0.1×	20	370
A. Tschernia United States	8	31 0.3×	81 1.7×	43 1.1×	29 1.1×	10 0.4×	12	420
M. Kraytman Belgium	6	57 0.6×	41 0.9×	6 0.1×	66 2.4×	3 0.1×	23	256
Dagmara I. Moscoso United States	6	8 0.1×	119 2.5×	43 1.1×	45 1.7×	4 0.2×	9	268

Countries citing papers authored by Mark Plautz

Since Specialization

Citations

This map shows the geographic impact of Mark Plautz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Plautz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Plautz more than expected).

Fields of papers citing papers by Mark Plautz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Plautz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Plautz. The network helps show where Mark Plautz may publish in the future.

Co-authorship network of co-authors of Mark Plautz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Plautz. A scholar is included among the top collaborators of Mark Plautz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Plautz. Mark Plautz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Niewoehner, Dennis E., et al.. (2009). Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 22(6). 587–592. 9 indexed citations

2.

Gonzales, Ralph, Eva Aagaard, Carlos A. Camargo, et al.. (2008). C-Reactive Protein Testing Does Not Decrease Antibiotic Use for Acute Cough Illness When Compared to a Clinical Algorithm. Journal of Emergency Medicine. 41(1). 1–7. 32 indexed citations

3.

Kesten, Steven, Mark Plautz, Craig A. Piquette, Michael P. Habib, & D. E. Niewoehner. (2007). Premature discontinuation of patients: a potential bias in COPD clinical trials. European Respiratory Journal. 30(5). 898–906. 34 indexed citations

4.

Plautz, Mark, et al.. (2000). Influence of cigarette smoking on crocidolite-induced ferritin release by human alveolar macrophages. Journal of Laboratory and Clinical Medicine. 136(6). 449–456. 3 indexed citations

5.

Plautz, Mark, et al.. (1999). Increased Concentrations of Iron and Isoferritins in the Lower Respiratory Tract of Patients with Stable Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 160(3). 796–801. 91 indexed citations

6.

Liewen, Michael B. & Mark Plautz. (1988). Occurrence of Listeria monocytogenes in Raw Milk in Nebraska. Journal of Food Protection. 51(11). 840–841. 24 indexed citations

7.

Calandra, Ricardo S., Mohamed A. Antar, Mark Plautz, et al.. (1970). Hormonal and metabolic studies in pheochromocytoma.. PubMed. 102(13). 1369–72. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact